Your browser doesn't support javascript.
loading
Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study.
Yamamoto, Takafumi; Imai, Norihiro; Kuzuya, Teiji; Yokoyama, Shinya; Yamamoto, Kenta; Ito, Takanori; Ishizu, Yoji; Honda, Takashi; Ishigami, Masatoshi.
Afiliación
  • Yamamoto T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Imai N; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Kuzuya T; Department of Gastroenterology and Hepatology, Fujita Health University.
  • Yokoyama S; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Yamamoto K; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Ito T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Ishizu Y; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Honda T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
  • Ishigami M; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine.
Nutr Cancer ; 74(9): 3118-3127, 2022.
Article en En | MEDLINE | ID: mdl-35285364

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2022 Tipo del documento: Article